SCHEMBL30315264

SCHEMBL30315264

COC(=O)[C@H](Cc1ccc(O)cc1)Nc1nc(-c2cccnc2)nc2c1ncn2C(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 12/20 0.45
▸ CDK5 Q00535 11/20 0.45
▸ CCNB1 P14635 10/20 0.45
▸ CDK5R1 Q15078 10/20 0.45
▸ CCNB2 O95067 5/20 0.45
▸ CCNB3 Q8WWL7 5/20 0.45
▸ CDK2 P24941 13/20 0.43
▸ CDK9 P50750 3/20 0.43
▸ AHR P35869 1/20 0.43
▸ CDK4 P11802 7/20 0.42
▸ MAPK1 P28482 7/20 0.42
▸ CDK7 P50613 7/20 0.42
▸ CCNE1 P24864 7/20 0.42
▸ CCNH P51946 6/20 0.42
▸ CCND1 P24385 5/20 0.42
▸ CCNT1 O60563 2/20 0.42
▸ MNAT1 P51948 1/20 0.42
▸ CDK6 Q00534 1/20 0.42
▸ CCNA2 P20248 5/20 0.42
▸ CCNA1 P78396 5/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2313974 1.00 CDK1 (0.45) CDK1CDK5CCNB1CDK5R1CCNB2
SCHEMBL3242817 0.92 ITGB1 (0.46) CDK1CDK5CCNB1CDK5R1CCNB2
SCHEMBL2312171 0.89 CDK2 (0.46) CDK1CDK5CCNB1CDK5R1CCNB2
SCHEMBL2314283 0.83 CDK2 (0.47) CDK1CDK5CCNB1CDK5R1CCNB2
SCHEMBL2317564 0.81 AHR (0.62) CDK1CDK5CCNB1CDK5R1CCNB2
SCHEMBL2313988 0.80 CDK2 (0.42) CDK1CDK5CCNB1CDK5R1CCNB2
SCHEMBL21016422 0.80 CDK2 (0.48) CDK1CDK5CCNB1CDK5R1CDK2
SCHEMBL15422733 0.80 CDK2 (0.42) CDK1CDK5CCNB1CDK5R1CCNB2
SCHEMBL2315248 0.78 CDK2 (0.41) CDK1CDK5CCNB1CDK5R1CCNB2
SCHEMBL2311219 0.77 CDK2 (0.46) CDK1CDK5CCNB1CDK5R1CCNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3524604-B1 EXPANDED HEMATOPOIETIC STEM CELLS FROM CORD BLOOD AND THEIR THERAPEUTIC USE NOVARTIS AG (CH) 2023-03-29 — — EP disclosed
Send feedback